Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PU2A
|
|||
| Drug Name |
Boronic acid derivative 3
|
|||
| Synonyms |
PMID26413912-Compound-60
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
INFINITY PHARMACEUTICALS, INC BEHNKE, Mark, L. CASTRO, Alfredo, C. EVANS, Catherine, A. GRENIER, Louis GROGAN, Michael, J. LIU, Tao SNYDER, Daniel, A. TIBBITTS, Thomas, T
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H10BN3O3
|
|||
| Canonical SMILES |
B(C1=CC=C(C=C1)C2=NN=C(O2)C3=CN=CC=C3)(O)O
|
|||
| InChI |
1S/C13H10BN3O3/c18-14(19)11-5-3-9(4-6-11)12-16-17-13(20-12)10-2-1-7-15-8-10/h1-8,18-19H
|
|||
| InChIKey |
GUJFLRGCBMMKFL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.